{"id":533560,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-06-23] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T10:59:08.065000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-15.html","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions [2017-06-23] June 23, 2017 Our file number: 17-106422-736 The purpose of this Notice of Amendment is to notify the additions of Lixisenatide, Ozenoxacin and Reslizumab to the Human and Veterinary Prescription Drug Lists…","rawSnapshotUrl":"/api/snapshots/raw/533560","browseUrl":"https://replay.healtharchive.ca/job-6/20260303105908/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-15.html#ha_snapshot=533560","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}